Conversely, inhibiting miR-20a in two lung cancer cell lines lacking TβRII decreases tumorigenicity of cells through restoring TβRII expression and TGF-signaling (Fig. 5 and S3). This evidence concerns the gene TGFBR2 and lung cancer.